Prana Surgical
Medical device company developing a CT-guided, minimally invasive tissue excision system intended to localize and remove small pulmonary nodules and other soft-tissue targets while preserving healthy tissue. The team of surgeons, engineers, and product specialists advances device design, preclinical testing, regulatory submissions, and early clinical evaluation. The company has engaged in accelerator programs, industry partnerships, and investor fundraising and announced a rebranding and intention to expand the platform beyond lung-specific applications.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Minimally invasive CT-guided tissue excision system
Integrated system designed to localize and excise small pulmonary nodules using CT-guidance, specialized surgical access tools, and an electrosurgical instrument employing bipolar radiofrequency to seal tissue during excision.
Minimally invasive CT-guided tissue excision system
Integrated system designed to localize and excise small pulmonary nodules using CT-guidance, specialized surgical access tools, and an electrosurgical instrument employing bipolar radiofrequency to seal tissue during excision.
Services
Collaboration with clinical sites and investigators to initiate and conduct first-in-human and subsequent clinical studies for minimally invasive tissue excision devices.
Collaboration with clinical sites and investigators to initiate and conduct first-in-human and subsequent clinical studies for minimally invasive tissue excision devices.
Expertise Areas
- Minimally invasive surgical device development
- Image-guided interventions using CT
- Electrosurgical instrument design
- Preclinical large-animal testing and translational studies
Key Technologies
- CT-guided targeting and localization
- Image-guided minimally invasive surgical systems
- Bipolar radiofrequency electrosurgical sealing
- Bench and preclinical verification/validation testing
News & Updates
Company announced rebrand to Prana Surgical and stated intent to expand platform beyond lung applications.
Series A extension was oversubscribed, bringing total reported funding to $9 million to support product development and clinical/regulatory plans.
Selected for MedTech Innovator's 2023 accelerator cohort as part of a program for medical technology startups.
Company blog discussing applications and potential of artificial intelligence in lung cancer detection, research, and care pathways.
Awarded a $3 million grant from the Cancer Prevention and Research Institute of Texas to fund commercialization activities and first-in-human studies.
Announcement of appointment of a senior clinical strategy officer to support clinical planning and investigator engagement.
Company announced rebrand to Prana Surgical and stated intent to expand platform beyond lung applications.
Series A extension was oversubscribed, bringing total reported funding to $9 million to support product development and clinical/regulatory plans.
Selected for MedTech Innovator's 2023 accelerator cohort as part of a program for medical technology startups.
Company blog discussing applications and potential of artificial intelligence in lung cancer detection, research, and care pathways.
Awarded a $3 million grant from the Cancer Prevention and Research Institute of Texas to fund commercialization activities and first-in-human studies.
Announcement of appointment of a senior clinical strategy officer to support clinical planning and investigator engagement.